Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays

• Main Authors: Göbbert Christian, Schulze-Isfort Christian, Wohlleben Wendel, Hahn Daniela, Rommel Christina, Dierker Christian, Kroll Alexandra, Voetz Matthias, Hardinghaus Ferdinand, Schnekenburger Jürgen
• Format: Article
• Language: English
• Published: BMC 2011-02-01
• Series: Particle and Fibre Toxicology
• Online Access: http://www.particleandfibretoxicology.com/content/8/1/9

<p>Abstract</p> <p>Background</p> <p>Engineered nanomaterials display unique properties that may have impact on human health, and thus require a reliable evaluation of their potential toxicity. Here, we performed a standardized <it>in vitro </it>screening of 23 engineered nanomaterials. We thoroughly characterized the physicochemical properties of the nanomaterials and adapted three classical <it>in vitro </it>toxicity assays to eliminate nanomaterial interference. Nanomaterial toxicity was assessed in ten representative cell lines.</p> <p>Results</p> <p>Six nanomaterials induced oxidative cell stress while only a single nanomaterial reduced cellular metabolic activity and none of the particles affected cell viability. Results from heterogeneous and chemically identical particles suggested that surface chemistry, surface coating and chemical composition are likely determinants of nanomaterial toxicity. Individual cell lines differed significantly in their response, dependent on the particle type and the toxicity endpoint measured.</p> <p>Conclusion</p> <p><it>In vitro </it>toxicity of the analyzed engineered nanomaterials cannot be attributed to a defined physicochemical property. Therefore, the accurate identification of nanomaterial cytotoxicity requires a matrix based on a set of sensitive cell lines and <it>in vitro </it>assays measuring different cytotoxicity endpoints.</p>